Volume 77, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


We used molecular xenomonitoring (MX, detection of filarial DNA in mosquitoes) to evaluate the impact of mass drug administration (MDA) in sentinel locations in Egypt with high (11.5%) and low (4.1%) baseline microfilaria prevalence rates. Blood-fed were pooled by household and tested for DNA by PCR. There was no significant relationship between the infection status of household residents and parasite DNA status of mosquitoes from the same houses. After 5 MDA rounds, parasite DNA rates in mosquitoes in high- and low-prevalence areas were reduced by 93.8% and 100% to 0.19% (95% CI: 0.076–0.382%) and 0% (95% CI: 0–0.045%), respectively. These changes were consistent with decreases in microfilaria prevalence rates in these sites; they provide insight regarding the minimal mosquito DNA rates necessary for sustained transmission of filariasis in Egypt. We conclude that MX is a powerful tool for monitoring the impact of MDA on filariasis endemicity and transmission.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, 2006. Global program to eliminate lymphatic filariasis. Wkly Epidemiol Rec 81 : 221–232. [Google Scholar]
  2. World Health Organization, 1997. Elimination of lymphatic filariasis as a public health problem—resolution of the executive board of the WHO. 50th World Health Assembly, May 6, 1997, Geneva, Switzerland. Geneva: WHO. WHA 50.29.
  3. Ottesen EA, Ismail MM, Horton J, 1999. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 15 : 382–386. [Google Scholar]
  4. Gad AM, Riad IM, Farid HA, 1995. Host-feeding patterns of Culex pipiens and Culex antennatus (Diptera: Culicidae) from a village in Sharqiya Governorate, Egypt. J Med Entomol 32 : 573–577. [Google Scholar]
  5. World Health Organization, 2002. Defining the roles of vector control and xenomonitoring in the global programme to eliminate lymphatic filariasis. Report of the informal consultation WHO/HQ, Geneva, 29–31 January 2002. Geneva: WHO, 42 pp. WHO/CDS/CPE/PVC/2002.3.
  6. World Health Organization, 2004. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis. Wkly Epidemiol Rec 79 : 358–365. [Google Scholar]
  7. Bockarie MJ, Alexander ND, Hyun P, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW, 1998. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. Lancet 351 : 162–168. [Google Scholar]
  8. Farid HA, Hammad RE, Hassan MM, Morsy ZS, Kamal IH, Weil GJ, Ramzy RMR, 2001. Detection of Wuchereria bancrofti in mosquitoes by the polymerase chain reaction: a potentially useful tool for large-scale control programmes. Trans R Soc Trop Med Hyg 95 : 29–32. [Google Scholar]
  9. Williams SA, Laney SJ, Biewert L, Saunders LJ, Boakye DA, Fischer P, Goodman DS, Helmy H, Hoti SL, Lammie PJ, Plichart C, Ramzy R, Ottesen EA, 2002. The mosquito PCR project: to develop a rapid assessment tool for the detection of Wuchereria bancrofti infected mosquitoes. Ann Trop Med Parasitol 96 : S41–S46. [Google Scholar]
  10. Goodman DS, Orelus JN, Roberts JM, Lammie PJ, Streit TG, 2003. PCR and mosquito dissection as tools to monitor filarial infection levels following mass treatment. Filaria J 2 : 11. [Google Scholar]
  11. Ramzy RMR, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ, 2006. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367 : 992–999. [Google Scholar]
  12. Weil GJ, Ramzy RM, El Setouhy M, Kandil AM, Ahmed ES, Faris R, 1999. A longitudinal study of bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow-up. Am J Trop Med Hyg 61 : 53–58. [Google Scholar]
  13. Ramzy RMR, El Setouhy M, Helmy H, Kandil AM, Ahmed ES, Farid HA, Faris R, Weil GJ, 2002. The impact of single-dose diethylcarbamazine treatment of bancroftian filariasis in a low-endemicity setting in Egypt. Am J Trop Med Hyg 6 : 196–200. [Google Scholar]
  14. Dean AG, Dean JA, Coulombier D, Burton AH, Brendel KA, Smith DC, Dicker RC, Sullivan KM, Fagan RF, 1994. EpiInfo, Version 6: A Word Processing, Database, and Statistics Program for Epidemiology on Microcomputers. Atlanta, GA: Centers for Disease Control and Prevention.
  15. Ramzy RMR, Helmy H, El-Leethy AST, Kandil AM, Ahmed ES, Weil GJ, Faris R, 1999. Field evaluation of a rapid-format kit for diagnosis of bancroftian filariasis in Egypt. East Mediterr Health J 5 : 880–887. [Google Scholar]
  16. Zhong M, McCarthy J, Bierwert L, Lizotte MR, Chanteau S, Nutman T, Ottesen EA, Williams SA, 1996. A PCR assay for detection of the parasite Wuchereria bancrofti in human blood samples. Am J Trop Med Hyg 54 : 357–363. [Google Scholar]
  17. Helmy H, Fischer P, Farid HA, Bradley MH, Ramzy RMR, 2004. Test strip detection of Wuchereria bancrofti amplified DNA in wild-caught Culex pipiens and estimation of infection rate by a PoolScreen algorithm. Trop Med Int Health 9 : 158–163. [Google Scholar]
  18. Gad AM, Feinsod FM, Soliman BA, Nelson GO, Gibbs PH, Shoukry A, 1994. Exposure variables in bancroftian filariasis in the Nile Delta. J Egypt Soc Parasitol 24 : 439–455. [Google Scholar]
  19. Southgate B, 1992. The significance of low density microfilaremia in the transmission of lymphatic filarial parasites. J Trop Med Hyg 95 : 79–86. [Google Scholar]
  20. Stolk W, Oortmarssen GV, Subramanian S, Das P, Borsboom G, Habbema J, Vlas SD, 2004. Assessing density dependence in the transmission of lymphatic filariasis: uptake and development of Wuchereria bancrofti microfilariae in the vector mosquitoes. Med Vet Entomol 18 : 57–60. [Google Scholar]
  21. Farid HA, Morsy ZS, Hassan AN, Hammad RE, Faris R, Kandil AM, Ahmed ES, Weil GJ, 2000. The impact of environmental and entomological factors on intervillage filarial focality in the Nile Delta. J Egypt Soc Parasitol 30 : 469–485. [Google Scholar]
  22. Fischer PU, Ericson SM, Fischer K, Fuchs JF, Rao RU, Christensen BM, Weil GJ, 2007. Persistence of Brugia malayi DNA in vector and non-vector mosquitoes: implications for xenomonitoring and transmission monitoring of lymphatic filariasis. Am J Trop Med Hyg 76 : 502–507. [Google Scholar]
  23. Ribeiro JM, Seulu F, Abose T, Kidane G, Teklehaimanot A, 1996. Temporal and spatial distribution of anopheline mosquitoes in an Ethiopian village: implications for malaria control strategies. Bull World Health Organ 74 : 299–305. [Google Scholar]
  24. Van Der Hoek W, Konradsen F, Amerasinghe PH, Perera D, Piyaratne MK, Amerasinghe FP, 2003. Towards a risk map of malaria for Sri Lanka: the importance of house location relative to vector breeding sites. Int J Epidemiol 32 : 280–285. [Google Scholar]
  25. Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW, 2002. Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med 347 : 1841–1848. [Google Scholar]
  26. Weil GJ, Ramzy RMR, 2007. Diagnostic tools for filariasis elimination programmes. Trends Parasitol 23 : 78–82. [Google Scholar]
  27. Michael E, Malecela-Lazaro MN, Kabali C, Snow LC, Kazura JW, 2006. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol 22 : 226–233. [Google Scholar]
  28. Farid HA, Kamal SA, Weil GJ, Adham FK, Ramzy RMR, 2003. Filariasis elimination in Egypt: impact of low microfilaraemics as sources of infection for mosquitoes. East Mediterr Health J 9 : 863–872. [Google Scholar]
  29. Burkot T, Ichimori K, 2002. The PacELF programme: will mass administration be enough? Trends Parasitol 18 : 109–115. [Google Scholar]
  30. Lammie PJ, Weil G, Noordin R, Kaliraj P, Steel C, Goodman D, Lakshmikanthan VB, Ottesen E, 2004. Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis—a multicenter trial. Filaria J 3 : 9. [Google Scholar]
  31. Rao RU, Atkinson LJ, Ramzy RMR, Helmy H, Farid HA, Bockarie MJ, Susapu M, Laney SJ, Williams SA, Weil GJ, 2006. A real-time PCR-based assay for detection of Wuchereria bancrofti DNA in blood and mosquitoes. J Trop Med Hyg 74 : 826–832. [Google Scholar]
  32. Chadee DD, Beier JC, 1996. Natural variation in blood-feeding kinetics of four mosquito vectors. J Vector Ecol 21 : 150–155. [Google Scholar]
  33. Chadee DD, Williams SA, Ottesen EA, 2002. Xenomonitoring of Culex quinquefasciatus mosquitoes as a guide for detecting the presence or absence of lymphatic filariasis: a preliminary protocol for mosquito sampling. Ann Trop Med Parasitol 96 : S47–S53. [Google Scholar]
  34. Ramzy RMR, Farid HA, Kamal IH, Ibrahim GH, Morsy ZS, Faris R, Weil GJ, Williams SA, Gad AM, 1997. A polymerase chain reaction-based assay for detection of Wuchereria bancrofti in human blood and Culex pipiens. Trans R Soc Trop Med Hyg 91 : 156–160. [Google Scholar]
  35. Michael E, Ramaiah KD, Hoti SL, Barker G, Paul MR, Yuvaraj J, Das PK, Molyneux DH, Zagaria N, 2002. Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol 96 : S15–S40. [Google Scholar]

Data & Media loading...

  • Received : 06 Mar 2007
  • Accepted : 13 Jun 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error